Mental DailyMental Daily
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • My Bookmarks
Aa
Mental Daily
Aa
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • Opinion
Search
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • My Bookmarks
Follow US
  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store
© 2022 - Mental Daily. All Rights Reserved.
Clinical

How metformin action could be inhibited by a molecule in gut bacteria

Staff Writer
Staff Writer 2 years ago
Updated 2021/05/12 at 6:34 PM
Share
SHARE

The effects of a drug often used by clinicians to treat blood sugar fluctuations associated with diabetes could be inhibited by action from a bacteria-derived in our intestinal system, a study at the University of Gothenburg has determined.

The treatment is known as metformin and has been widely prescribed by physicians for treating type 2 diabetes. However, in a recent study released in Cell Metabolism, the action of metformin may be inhibited by the molecule imidazole propionate produced by bacteria in the gut.

According to researchers, the change in gut microbiota pertaining to one’s diabetes condition could heighten the production of imidazole propionate, which results in an inhibitory effect.

“Our study demonstrates clearly that imidazole propionate not only inhibits the effects of insulin but may also reduce the therapeutic action of the metformin,” a co-author of the study stated in a press release.


“Since imidazole propionate has also been linked to inflammation in the gut, and metformin has several side effects in the form of intestinal problems, it’s conceivable that imidazole propionate both blocks the treatment effect and contributes to side effects of metformin. But new studies are needed to verify this hypothesis,” the author concluded.

The study was authored by Ara Koh, Louise Manneras-Holm, Rosie Perkins, Fredrik Bäckhed, among other researchers.

You Might Also Like

New study explores test that can detect Alzheimer’s years before diagnosis

Prenatal exposure to pollution may be linked to lower cognitive scores in infants

Researchers unveil new drug candidate to help treat adrenoleukodystrophy

New research finds Alzheimer’s risk factors affect males and females very differently

Study suggests gut microbes may control body temperature

TAGGED: bacteria, gut microbiome, metformin, type 2 diabetes
Staff Writer November 29, 2020
Share this Article
Facebook Twitter Whatsapp Whatsapp Email Print
Previous Article U.S. rates of cigarette smoking have not increased, vaping rates are rising though
Next Article Incidences of nonalcoholic fatty liver disease in children increased over the last decade

Recommended

Clinical

New study explores test that can detect Alzheimer’s years before diagnosis

1 Min Read
Clinical

Prenatal exposure to pollution may be linked to lower cognitive scores in infants

1 Min Read
Clinical

Researchers unveil new drug candidate to help treat adrenoleukodystrophy

1 Min Read
Clinical

New research finds Alzheimer’s risk factors affect males and females very differently

1 Min Read
//

We are a trusted online source for research news and resources on all aspects of the mind and human behavior.

Verticals

  • Clinical
  • Health
  • Social
  • I/O
  • Opinion

Social

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Links

  • About
  • Contact
  • The Editor
  • Terms & Conditions
  • Privacy Policy
Follow US

© 2022 Mental Daily. All Rights Reserved.

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?